These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 39281418)
21. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD). Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304 [TBL] [Abstract][Full Text] [Related]
22. The prognostic value of soluble Klotho in patients with haemodialysis: a systematic review and meta-analysis. Liu QF; Li SS; Yu LX; Feng JH; Xue LL; Lu GY Ther Adv Chronic Dis; 2020; 11():2040622320940176. PubMed ID: 35154625 [TBL] [Abstract][Full Text] [Related]
23. α-Klotho is associated with cardiovascular and all-cause mortality in patients with stage 3b and 4 chronic kidney disease (CKD): a long-term prospective cohort study. Milovanova LY; Nezhdanov KS; Milovanova SY; Lebedeva MV; Beketov VD; Volkov AV; Kamyshova ES; Suvorov AY; Moiseev SV J Nephrol; 2024 Sep; ():. PubMed ID: 39223354 [TBL] [Abstract][Full Text] [Related]
24. Low protein diets for non-diabetic adults with chronic kidney disease. Hahn D; Hodson EM; Fouque D Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724 [TBL] [Abstract][Full Text] [Related]
25. Glucose targets for preventing diabetic kidney disease and its progression. Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069 [TBL] [Abstract][Full Text] [Related]
26. Low protein diets for non-diabetic adults with chronic kidney disease. Hahn D; Hodson EM; Fouque D Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160 [TBL] [Abstract][Full Text] [Related]
27. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease. Liu QF; Ye JM; Yu LX; He AL; Sun Q; He DW; Li SS J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648 [TBL] [Abstract][Full Text] [Related]
28. Continuous infusion versus bolus injection of loop diuretics for acute heart failure. Rasoul D; Zhang J; Farnell E; Tsangarides AA; Chong SC; Fernando R; Zhou C; Ihsan M; Ahmed S; Lwin TS; Bateman J; Hill RA; Lip GY; Sankaranarayanan R Cochrane Database Syst Rev; 2024 May; 5(5):CD014811. PubMed ID: 38775253 [TBL] [Abstract][Full Text] [Related]
29. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Palmer SC; Saglimbene V; Mavridis D; Salanti G; Craig JC; Tonelli M; Wiebe N; Strippoli GF Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010590. PubMed ID: 25486075 [TBL] [Abstract][Full Text] [Related]
30. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials. Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236 [TBL] [Abstract][Full Text] [Related]
31. Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. Sullivan MK; Rankin AJ; Jani BD; Mair FS; Mark PB BMJ Open; 2020 Jun; 10(6):e038401. PubMed ID: 32606067 [TBL] [Abstract][Full Text] [Related]
32. Circulating α-klotho levels in CKD and relationship to progression. Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260 [TBL] [Abstract][Full Text] [Related]
33. Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis. Memmos E; Sarafidis P; Pateinakis P; Tsiantoulas A; Faitatzidou D; Giamalis P; Vasilikos V; Papagianni A BMC Nephrol; 2019 Jun; 20(1):217. PubMed ID: 31185930 [TBL] [Abstract][Full Text] [Related]
34. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis. Sekercioglu N; Busse JW; Sekercioglu MF; Agarwal A; Shaikh S; Lopes LC; Mustafa RA; Guyatt GH; Thabane L Ren Fail; 2016 Jul; 38(6):857-74. PubMed ID: 27137817 [TBL] [Abstract][Full Text] [Related]
36. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease. Cambray S; Bermudez-Lopez M; Bozic M; Valdivielso JM; Clin Kidney J; 2020 Dec; 13(6):1017-1024. PubMed ID: 33391745 [TBL] [Abstract][Full Text] [Related]
38. Discontinuation of Renin-Angiotensin System Inhibitors and Clinical Outcomes in Chronic Kidney Disease: A Systemic Review and Meta-Analysis. Tang C; Wen XY; Lv JC; Shi SF; Zhou XJ; Liu LJ; Zhang H Am J Nephrol; 2023; 54(5-6):234-244. PubMed ID: 37231791 [TBL] [Abstract][Full Text] [Related]
39. Effects of sodium-glucose co-transporter-2 inhibitors on kidney, cardiovascular, and safety outcomes in patients with advanced chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials. Cao H; Rao X; Jia J; Yan T; Li D Acta Diabetol; 2023 Mar; 60(3):325-335. PubMed ID: 36316605 [TBL] [Abstract][Full Text] [Related]